PT Bank Central Asia Tbk
PT Bank Central Asia Tbk (PBCRF) Financial Performance & Income Statement Overview
Analyze PT Bank Central Asia Tbk (PBCRF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
PT Bank Central Asia Tbk (PBCRF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for PT Bank Central Asia Tbk PBCRF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $28667.25B | $28361.96B | $28397.31B | $29171.40B |
| Cost of Revenue | $0.00 | $0.00 | -$2368.82B | $0.00 |
| Gross Profit | $28667.25B | $28361.96B | $30766.13B | $29171.40B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.08 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2708.79B | $4454.004B | $3267.60B | $2888.73B |
| Operating Expenses | $10214.93B | $11315.62B | $9826.75B | $3483.15B |
| Total Costs & Expenses | $10214.93B | $11315.62B | $13127.43B | $11873.54B |
| Interest Income | $24173.81B | $24406.49B | $24086.58B | $22960.07B |
| Interest Expense | $2549.37B | $2483.59B | $2525.46B | $2330.68B |
| Depreciation & Amortization | $650.24B | $604.11B | $543.95B | $442.03B |
| EBITDA | $0.00 | $0.00 | $18167.63B | $0.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.64 | $0.00 |
| Operating Income | $18452.32B | $17046.34B | $18167.63B | $17307.54B |
| Operating Income Ratio | $0.64 | $0.60 | $0.64 | $0.59 |
| Other Income/Expenses (Net) | -$996.66B | $325.25B | -$543.95B | -$1221.98B |
| Income Before Tax | $17455.66B | $17371.60B | $17623.69B | $17307.54B |
| Income Before Tax Ratio | $0.61 | $0.61 | $0.62 | $0.59 |
| Income Tax Expense | $3308.67B | $3608.21B | $3413.30B | $3308.55B |
| Net Income | $14146.13B | $13762.44B | $14197.68B | $13996.70B |
| Net Income Ratio | $0.49 | $0.49 | $0.50 | $0.48 |
| EPS | $115.00 | $111.64 | $115.17 | $113.54 |
| Diluted EPS | $115.00 | $111.64 | $115.17 | $113.54 |
| Weighted Avg Shares Outstanding | $123.27B | $123.28B | $123.28B | $123.28B |
| Weighted Avg Shares Outstanding (Diluted) | $123.27B | $123.28B | $123.28B | $123.28B |
Financial performance has remained strong, with revenue growing from $29171.40B in Q2 2024 to $28667.25B in Q1 2025. Gross profit continued to perform well, with margins at 100% in the latest quarter. Operating income reached $18452.32B in Q1 2025, holding a steady 64% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $0.00. Net income rose to $14146.13B, keeping EPS at $115.00. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan